• Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process
Trusted Solutions. Advanced Technology. Uncompromising Quality.
  • Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process

Graft survival

Graft survival

Evidence-Based Recommendations for the Use of Machine Perfusion in Kidney Transplantation

Machine perfusion is becoming essential in Indian kidney transplantation as reliance on marginal donors (ECD, DCD) grows. This expert consensus, developed with NOTTO, recommends HMP for all DCD [...]

Read More
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Read More
Impact of HOPE on Very Old DCD (>70 Years) Livers: Insights From A Belgian Bi-centeric Experience

Impact of HOPE on Very Old DCD (>70 Years) Livers: Insights From A Belgian Bi-centeric Experience

This bi-centric Belgian study evaluated the impact of end-ischemic HOPE (Hypothermic Oxygenated Perfusion) on very old DCD liver grafts (?70 years old). Compared with static cold storage, HOPE [...]

Read More
Success Of Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (hope) Prior To Liver Transplantation – The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The VitaSmart Liver Machine Perfusion System

Success Of Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (hope) Prior To Liver Transplantation – The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The VitaSmart Liver Machine Perfusion System

The Bridge to HOPE trial is a pivotal multicenter randomized controlled study in the US comparing HOPE via the VitaSmart liver machine to standard static cold storage (SCS) for extended […]

Read More
Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney Transplants

Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney Transplants

Large cohort analysis assessing kidney outcomes by preservation solution, reporting reduced graft survival associated with HTK versus UW. This supports the cross-organ trend that preservation [...]

Read More
Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Registry-based analysis demonstrating reduced graft survival associated with HTK in deceased donor liver transplantation, with the strongest signal in DCD livers. This publication is commonly [...]

Read More
Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas Transplantation

Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas Transplantation

UNOS-based analysis evaluating preservation solution impact in pancreas transplantation, reporting that HTK use was associated with reduced graft survival compared with UW. Frequently cited as [...]

Read More
Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long-Term Graft Outcome Study From the European Liver Transplant Registry

Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long-Term Graft Outcome Study From the European Liver Transplant Registry

Large European registry analysis evaluating long-term graft outcomes across preservation solutions in liver transplantation. The study highlights clinically meaningful differences in graft [...]

Read More
Outcomes of redo-liver transplantation using hypothermic oxygenated machine perfusion: A multicentre cohort study (REDO-HOPE),

Outcomes of redo-liver transplantation using hypothermic oxygenated machine perfusion: A multicentre cohort study (REDO-HOPE),

This multicenter cohort study investigates outcomes of redo-liver transplantation (redo-LT) using grafts treated with hypothermic oxygenated machine perfusion (HOPE) across seven Italian centers. [...]

Read More

Latest Posts

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

August 27, 2026

DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of […]

Read more
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

August 12, 2026

Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a […]

Read more
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

June 23, 2026

Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA […]

Read more




full

info@b2ll.com

US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA

© 2026 Bridge to Life™ Ltd. All rights reserved.

EVENTS



Sep


15


September 15 – September 16


National Critical Issues Forum



Sep


16


September 16 – September 17


XIII International Course on HPB surgery



Sep


16


September 16 – September 18


SFPC


View Calendar


EXPLORE BTL

Products

Contact & Support

About

Recent News

Privacy Policy

Social Responsibility

Certifications

JOIN OUR EMAIL LIST

SOCIAL MEDIA

Linkedin

X

VitaSmart™ is available in Europe, Saudi Arabia, India, and in all countries accepting the CE mark. VitaSmart™ Hypothermic Oxygenated Perfusion System is authorized to be sold in the US market, pending regulatory approval in all other countries.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search